AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 293 min read$AMRZ

Amrize (AMRZ) Q3 2026 Earnings Call Transcript

Amrize (AMRZ) reported Q3 2026 earnings, highlighting strong pricing growth and operational efficiency. The company saw solid commercial roofing momentum but softer residential roofing due to lower home sales. Amrize completed $262M in CapEx and acquired PB Materials and Rapid Redi-Mix, strengthening its Texas market presence. The company returned $1.1B to shareholders via dividends and share repurchases, completing a $1B buyback program.

Original reporting
finance.yahoo.com
Published Oct 29, 2026, 7:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 8:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Amrize (AMRZ) Q3 2026 Earnings Call Transcript — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$AMRZNeutralMed
01

Why it matters

The disclosed financial metrics and strategic actions give traders fresh data to reassess valuation and short‑term price direction.

02

Market read

Earnings release offers new guidance and cash return details, influencing investor sentiment on Amrize and peers.

03

What to watch

Potential slowdown from elevated interest rates and weather‑related construction delays.

Relevance 7/10Novelty 7/10Timing: after-hours release

Background

Amrize provided its Q3 2026 earnings call transcript, highlighting operational performance, capital allocation, and shareholder returns.

Company-level read

Ticker impact

$AMRZNeutralHigh confidence
Context

Q3 2026 earnings call disclosed $262M capex, $1B share repurchase completion, and $0.11 dividend.

Expected impact

likely modest pressure as market prices in mixed guidance and high capex spend

Evidence & confidence

New earnings numbers and capital actions provide fresh data for valuation, but no clear upside catalyst.

Market effects

Sector

Construction materials sector may see broader impact from Amrize's pricing and freight surcharge trends.

Regional

North American markets could react to Amrize's infrastructure exposure and dividend payout.

Global

Limited to investors tracking US-listed building materials firms.

Counterpoint

What could challenge this read

Despite strong cash returns, high capex and soft residential roofing could signal overextension.

Key entities

  • Company
    Amrize

    US‑listed building materials and construction firm.

Read at source← All news

Also covered by

4 outlets

Related articles

NOV 1
Med

Amrize Q3 2026 slides: pricing drives margins amid volume headwinds

Amrize reported Q3 2026 revenues of $3.77B, up 2.2% YoY, with net income rising 3.3% to $558M. Pricing initiatives and acquisitions offset volume declines due to weather. Building Materials segment grew 1.8%, while Building Envelope faced challenges. Guidance updated to $12.2B-$12.4B in revenue and $2.95B-$3.05B in adjusted EBITDA for 2026.

investing.com2 min
OCT 30
$AMRZMed

DA Davidson raises Amrize stock price target to $43 on mixed Q3

DA Davidson raised its price target for Amrize (NYSE:AMRZ) to $43, citing mixed Q3 results with strong Building Materials offset by Building Envelope pressure. The stock is up 5.5% weekly but down 22% in six months. Amrize guided below consensus but beat EPS estimates by 2.06% while missing revenue by 0.95%. DA Davidson maintains a Neutral rating, awaiting more execution visibility.

investing.com2 min
OCT 30
$AMRZHighAI 9/10

What Amrize (AMRZ) Said on Its Q3 Earnings Call

Amrize (AMRZ) reported Q3 revenue growth of 1.8% to $2.8B in Building Materials and 3.6% to $929M in Building Envelope. Adjusted EBITDA rose 2.7% in Building Materials but fell 14.6% in Building Envelope due to higher costs. The company expects price-over-cost positivity in Building Envelope by 2027. Amrize reaffirmed its 2026 outlook, targeting $12.2B-$12.4B in revenue and $2.95B-$3.05B in EBITDA. It returned $1.1B to shareholders through dividends and repurchases.

finance.yahoo.com3 min
OCT 29
$AMRZMed

Amrize Ltd (AMRZ) Q3 2026 Earnings Call Highlights: Pricing Power Drives Growth

Amrize Ltd (AMRZ) reported Q3 2026 earnings, with revenue and EBITDA guidance updated to $12.2-$12.4B and $2.95-$3.05B. Cement volumes fell 4.2% YoY due to weather, while building envelope EBITDA declined 14.6% from inflation. Price-cost positivity in building envelope delayed to 2027. CEO Jan Jenisch expects 2027 growth but cites inflation and interest rate uncertainties. Free cash flow conversion below 50% target due to higher CapEx.

finance.yahoo.com6 min
OCT 29
Med

Why is Amrize stock sliding today?

Amrize AG's stock is down 5.3% in pre-market trading after Q3 2026 results missed revenue expectations and the company lowered its full-year adjusted EBITDA guidance to $2.95–$3.05 billion. Revenue was $3.77 billion, up 2.2% YoY but below consensus. Management cited inflation-driven cost increases. The stock is near its 52-week low.

investing.com2 min